The patient was on drugs Inj. CEFTAZIDIME 1g BD from POD:0-5; Inj. TEICOPLANIN 200mg BD from POD:1-11; Inj. PANTOPRAZOLE 40mg BD POD: 0-4 which was changed to Tab. PANTOPRAZOLE 40mg OD BBF POD:5-13, Inj. METHYLPREDNISOLONE 125mg BD POD:1-11; Inj. ONDANSETRON and TRAMADOL were given as STAT drugs on POD:0,1; Tab. MYCOPHENOLIC ACID 360mg BD as immunosuppressants from POD:0-13 ; Tab. TACROLIMUS 1mg BD as immunosuppressants from POD:2-13; Tab. AMLODIPINE POD:3-7 for his elevated Blood Pressure (BP) levels; Syrup GELUSIL 2 tsp TID POD:0-5 for his constipation; Tab. SULFAMETHOXAZOLE+TRIMETHOPRIM OD as prophylactic anti-bacterial from POD:5-11 which was withheld due to hyperkalemia; Tab. VALGANCICLOVIR 450mg OD as prophylactic anti-viral from POD:5-13; Tab. FLUCONAZOLE 150mg Alternate date as prophylactic anti-fungal from POD:5-13; Syrup POTKLOR 10ml TID POD:6-11; K-BIND Sachets POD:11-13 for hyperkalemia; Tab. AMOXICILLIN+POTASSIUM CLAVULANATE 625mg BD as antibiotic from POD:10-13; Tab. PREDNISOLONE 10mg BD as immunosuppressant from POD:11-13.

The patient was discharged on 7 February 2022 POD-13 and was advised to review after one week (on 15 February 2022) in the OPD with repeat Renal Function Tests. The medications advised were Tab. WYSOLONE 10mg BD; Tab. TACROLIMUS 2mg BD; Tab. MYCOPHENOLIC ACID 360mg BD; Tab. PANTOPRAZOLE 40mg OD BBF; Tab. AMOXICILLIN+POTASSIUM CLAVULANATE 625mg BD (3 days); K-BIND Sachets BD (until next follow-up).